Fosamax (alendronate) is an oral bisphosphonate prescribed to treat osteoporosis, a condition which makes the bones brittle and prone to breaks.
While Fosamax and other bisphosphonates are beneficial in the treatment of osteoporosis, Paget’s disease, and other bone diseases, this potentially dangerous drug has been linked to a heightened incidence of esophageal cancer and other Fosamax side effects.
If you or a loved one has been diagnosed with esophageal cancer after taking Fosamax or another osteoporosis medication, you may be entitled to collect significant compensation in a pharmaceutical product liability lawsuit. Lawyers at Bernheim Dolinsky Kelley who experienced in this type of litigation are currently reviewing cases and can offer you a free legal consultation.
The esophagus is the tube that connects the throat to the stomach. When food has been chewed, the esophagus contracts in a process called peristalsis to move that food to the stomach. When the cells in a person’s esophagus form tumors and reproduce without control, that person likely has esophageal cancer. The two main types of esophageal cancer are:
Treatment for esophageal cancer is dependent on the size and location of tumors, but generally includes chemotherapy and radiation. There is a 17% average five-year survival rate for esophageal cancer patients.
When a person takes Fosamax, there is a chance that small particles of the drug will become lodged in the esophagus, and this could lead to esophageal cancer. Right now, the FDA is reviewing data from a number ofrespected studies to evaluate the potential link between Fosamax and other bisphosphonates and esophageal cancer. In an FDA Drug Safety Communication released in July of 2011, the agency stated that tests to link Fosamax to esophageal cancer have been inconclusive to date. However, by 2009, the FDA had received up to 23 reports of esophageal cancer in U.S. Fosamax users. At this time, 8 Fosamax users had died of the cancer. In a 2010 study published in the British Journal of Medicine, researchers reported that use of Fosamax or another bisphosphonate for more than 5 years can double the risk of esophageal cancer.
If you have been diagnosed with esophageal cancer after taking Fosamax or another bisphosphonate such as Actonel, Boniva, Atelvia, Skelid, or Didronel, you may be owed substantial compensation. Compensation from a Fosamax lawsuit can help victims and their families focus on treatment by alleviating worries about medical bills, lost wages, and other damages. To learn more about pharmaceutical product liability litigation and your potential right to compensation, contact an experienced personal injury lawyer today.
If you or someone you love has suffered a personal injury by a dangerous prescription medication, you should take action. We promise to thoroughly investigate the facts surrounding your personal injury situation, and give you an honest and straightforward explanation of your legal options.
Our clients mean the world to us. Call us at 8004744089, and let Bernheim Dolinsky Kelley prove it to you.
Helping families across the United States to get the justice and compensation they are due.